EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Circulating DICAM as a predictor of mortality in critically ill patients with acute kidney injury requiring continuous kidney replacement therapy

Dong-Kyu Lee, Yu-Kyung Chung, Youn-Sik Oh, Junyoung Park, You Hyun Jeon, Hee-Yeon Jung, Ji-Young Choi, Sun-Hee Park, Chan-Duck Kim, Jang-Hee Cho, Jeong-Hoon Lim

Nephron · 05.11.2026

DOI: 10.1159/nef/adtag014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephron, online erschienen am 05.11.2026. Verfasst von Dong-Kyu Lee und 10 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Acute kidney injury (AKI) is common in critically ill patients and is associated with high mortality, highlighting the need for reliable prognostic markers. This study evaluated dual immunoglobulin domain-containing cell adhesion molecule (DICAM), an inflammation-associated transmembrane protein, as a predictor of mortality in patients with AKI requiring continuous kidney replacement therapy (CKRT).

Methods

In this prospective multicenter cohort study, critically ill patients with AKI requiring CKRT were enrolled. Blood samples were obtained before CKRT initiation, and DICAM levels were measured in 115 patients. The primary outcome was in-hospital mortality. Associations between DICAM levels and mortality were assessed using Cox proportional hazards models, with DICAM analyzed as categorical and continuous variables.

Results

A total of 115 patients were included in the analysis. During hospitalization, 54 patients (47.0%) died. The mean age was 65.7 ± 14.8 years, and 88 patients (76.5%) were male. The median DICAM level was 13.8 ng/mL (interquartile range [IQR], 6.9–33.5), compared with 5.9 ng/mL (IQR, 5.0–6.9) in healthy controls. When analyzed as a categorical variable (high vs. low DICAM), higher DICAM levels were associated with increased in-hospital mortality (adjusted hazard ratio [aHR], 2.05; 95% confidence interval [CI], 1.11–3.76; P = 0.021). When analyzed as a continuous variable (per 1 ng/mL increase), DICAM remained independently associated with mortality (aHR, 1.015; 95% CI, 1.005–1.025; P = 0.001). DICAM showed higher discriminatory performance for in-hospital mortality (AUC, 0.729) than APACHE II score (0.557), SOFA score (0.580), albumin (0.559), NGAL (0.595), and GDF-15 (0.554) (all P < 0.05). DICAM levels were positively correlated with SOFA score (r = 0.216, P = 0.021), NGAL (r = 0.321, P < 0.001), GDF-15 (r = 0.284, P = 0.002), and lactate (r = 0.283, P = 0.026).

Conclusion

Elevated circulating DICAM levels are independently associated with increased in-hospital mortality in critically ill patients with AKI requiring CKRT. DICAM may serve as a novel prognostic biomarker in this population. Further studies are needed to validate these findings and clarify underlying mechanisms.

Zitieren

APA

Lee, D., Chung, Y., Oh, Y., Park, J., Jeon, Y. H., Jung, H., Choi, J., Park, S., Kim, C., Cho, J., & Lim, J. (2026). Circulating DICAM as a predictor of mortality in critically ill patients with acute kidney injury requiring continuous kidney replacement therapy. Nephron. https://doi.org/10.1159/nef/adtag014

Vancouver

Lee D, Chung Y, Oh Y, Park J, Jeon YH, Jung H, et al. Circulating DICAM as a predictor of mortality in critically ill patients with acute kidney injury requiring continuous kidney replacement therapy. Nephron. 2026. doi:10.1159/nef/adtag014

BibTeX
@article{Lee2026,
  author = {Lee, Dong-Kyu and Chung, Yu-Kyung and Oh, Youn-Sik and Park, Junyoung and Jeon, You Hyun and Jung, Hee-Yeon and Choi, Ji-Young and Park, Sun-Hee and Kim, Chan-Duck and Cho, Jang-Hee and Lim, Jeong-Hoon},
  title = {Circulating DICAM as a predictor of mortality in critically ill patients with acute kidney injury requiring continuous kidney replacement therapy},
  journal = {Nephron},
  year = {2026},
  doi = {10.1159/nef/adtag014}
}
Kostenlos starten →